Author:
Kurbacheva O M,Pavlova K S,Galitskaya M A
Abstract
It presents an analysis of international position papers, federal clinical recommendations and national publications focused on contraindications to allergen immunotherapy (AIT) in recent years. In details absolute and relative clinical contraindications to allergen immunotherapy (AIT) are described.
Reference89 articles.
1. http://ec.europa.eu/health/files/eudralex/vol2/c/smpc_ guideline_rev2_en.pdf (assessed 2 April 2015).
2. Pesek R.D., Lockey R.F. Treatment of Hymenoptera venom allergy: an update. Curr. Opin. Allergy Clin. Immunol. 2014, v. 14, p. 340-346.
3. Cox L., Nelson H., Lockey R. et al. Allergen immunotherapy: a practice parameter third update. J. Allergy Clin. Immunol. 2011, v. 127, p. 1-55.
4. Alvarez-Cuesta E., Bousquet J., Canonica G.W et al. EAACI, Immunotherapy Task Force. Standards for practical allergen-specific immunotherapy. J. Allergy. 2006, v. 61, p. 1-20.
5. Krishna M.T., Ewan P.W., Diwakar L. et al. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin. Exp. Allergy. 2011, v. 41, p. 1201-1220.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献